P3 Health Partners Inc
NASDAQ:PIII
Intrinsic Value
P3 Health Partners, Inc. is a population health care management company. [ Read More ]
The intrinsic value of one PIII stock under the Base Case scenario is 0.94 USD. Compared to the current market price of 0.501 USD, P3 Health Partners Inc is Undervalued by 47%.
Valuation Backtest
P3 Health Partners Inc
Run backtest to discover the historical profit from buying and selling PIII stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
P3 Health Partners Inc
Current Assets | 166m |
Cash & Short-Term Investments | 36.3m |
Receivables | 121.5m |
Other Current Assets | 8.2m |
Non-Current Assets | 695m |
PP&E | 8.7m |
Intangibles | 666.7m |
Other Non-Current Assets | 19.5m |
Current Liabilities | 299.4m |
Accounts Payable | 219m |
Accrued Liabilities | 80.4m |
Non-Current Liabilities | 419.5m |
Long-Term Debt | 108.3m |
Other Non-Current Liabilities | 311.1m |
Earnings Waterfall
P3 Health Partners Inc
Revenue
|
1.3B
USD
|
Cost of Revenue
|
-1.2B
USD
|
Gross Profit
|
31.6m
USD
|
Operating Expenses
|
-199.6m
USD
|
Operating Income
|
-167.9m
USD
|
Other Expenses
|
110.2m
USD
|
Net Income
|
-57.8m
USD
|
Free Cash Flow Analysis
P3 Health Partners Inc
What is Free Cash Flow?
PIII Profitability Score
Profitability Due Diligence
P3 Health Partners Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
P3 Health Partners Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
PIII Solvency Score
Solvency Due Diligence
P3 Health Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Score
P3 Health Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PIII Price Targets Summary
P3 Health Partners Inc
According to Wall Street analysts, the average 1-year price target for PIII is 2.856 USD with a low forecast of 0.909 USD and a high forecast of 4.725 USD.
Ownership
PIII Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PIII Price
P3 Health Partners Inc
Average Annual Return | -52.15% |
Standard Deviation of Annual Returns | 27.15% |
Max Drawdown | -96% |
Market Capitalization | 298.3m USD |
Shares Outstanding | 595 458 264 |
Percentage of Shares Shorted | 5.48% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
P3 Health Partners, Inc. is a population health care management company. The company is headquartered in Chicago, Illinois and currently employs 450 full-time employees. The company went IPO on 2021-02-10. The firm develops a network of primary care, specialty and ancillary providers managing the care. The company supports providers with administrative services and care coordination for Medicare Advantage patients. The firm navigates, coordinates and integrates care to create a customized care plan for each patient. The firm offers P3 care model that consists of education, tools and support to manage illness, prevention and wellness support, medication management, nursing support, access to community resources and services, and transition of care teams, which combine to form a single approach to patient care. Its technology offers data-backed solutions and care provision, seamless transition of payor and patient data across platforms, real-time data sharing, predictive analytics and risk stratification, and workflows across complex patient panels.
Contact
IPO
Employees
Officers
The intrinsic value of one PIII stock under the Base Case scenario is 0.94 USD.
Compared to the current market price of 0.501 USD, P3 Health Partners Inc is Undervalued by 47%.